IGC Pharma (IGC) Change in Cash (2010 - 2025)
IGC Pharma (IGC) reported Change in Cash of $651000.0 for Q3 2025, up 334.17% year-over-year from $149940.3 in Q3 2024, and up 1228.57% quarter-over-quarter from $49000.0 in Q2 2025.
IGC Pharma (IGC) Change in Cash (2010 - 2025) Analysis & Trends
IGC Pharma (IGC) has 16 years of Change in Cash data on file, last reported at $651000.0 in Q3 2025.
- Change in Cash for Q3 2025 came in at $651000.0, up 334.17% year-over-year; the trailing twelve-month figure through Sep 2025 was -$441000.0 (up 70.2% YoY), and the FY2026 annual result was -$693000.0, up 12.61% from the prior year.
- Change in Cash rose to $651000.0 in Q3 2025 per IGC's latest filing, from $49000.0 in the prior quarter.
- Over five years, Change in Cash peaked at $13.6 million in Q1 2021 and troughed at -$2.5 million in Q4 2021.
- A 5-year average of $7210.5 and a median of -$1.1 million in 2024 frame the typical range for Change in Cash.
- On a YoY basis, Change in Cash climbed as much as 573.01% in 2021 and fell as far as 1243.17% in 2021.
- A 5-year view of Change in Cash shows it stood at -$2.5 million in 2021, then jumped by 31.73% to -$1.7 million in 2022, then rose by 1.79% to -$1.6 million in 2023, then surged by 34.71% to -$1.1 million in 2024, then soared by 160.5% to $651000.0 in 2025.
- Business Quant data shows IGC's Change in Cash at $651000.0 in Q3 2025, $49000.0 in Q2 2025, and -$65000.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | 2.44 Mn |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | 623.00 Mn |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | -2.44 Mn |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | 417.10 Mn |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | -45.97 Mn |
| 10 | IGC Pharma | 27.49 Mn | 27.22 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 651,000.00 |
| Jun 30, 2025 | 49,000.00 |
| Mar 31, 2025 | -65,000.00 |
| Dec 31, 2024 | -1.08 Mn |
| Sep 30, 2024 | -278,000.00 |
| Jun 30, 2024 | 626,000.00 |
| Mar 31, 2024 | -180,000.00 |
| Dec 31, 2023 | -1.65 Mn |
| Sep 30, 2023 | 1.30 Mn |
| Jun 30, 2023 | -1.47 Mn |
| Mar 31, 2023 | -1.75 Mn |
| Dec 31, 2022 | -1.68 Mn |
| Sep 30, 2022 | -1.43 Mn |
| Jun 30, 2022 | -2.41 Mn |
| Mar 31, 2022 | -1.48 Mn |
| Dec 31, 2021 | -2.46 Mn |
| Sep 30, 2021 | 1.08 Mn |
| Jun 30, 2021 | -1.23 Mn |
| Mar 31, 2021 | 13.58 Mn |
| Dec 31, 2020 | -183,000.00 |